Our focus is on prescription drug rebates. How do they work? Why do they work? How do they benefit consumers? And why are they currently under attack by some policymakers and drug manufacturers?

The guest is Alex Brill, a health policy researcher and the founder and CEO of Matrix Global Advisors, an economic consulting firm specializing in healthcare, tax, and fiscal policy. He has extensive health policy research experience and previously served on the staff of the House Ways and Means Committee and the White House Council of Economic Advisers. Alex is also the author of a recent research study entitled “Understanding Drug Rebates and Their Role in Promoting Competition.”